Humana (HUM)
Humana on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as hospital & medical service plans.
3.7M
Short interest
settlement 2026-10-15
2.0
Days to cover
-0.3 days vs prior
39.1%
Short share of volume
2026-10-28
2,598
Fails to deliver
settlement 2026-09-21
Wed 4 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-10-28.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in HUM is 3,665,781 shares, up 818,478 shares over the last month. Over the last 48 readings it ranged from 2,789,982 shares (30 September 2026) to 6,323,340 shares (15 June 2026). At the reported average volume of 1.9M shares a day that is 2.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/hum" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 3,665,781 | +31.4% | 1,855,941 | 1.98 |
| 2026-09-30 | 2,789,982 | -2.0% | 1,244,216 | 2.24 |
| 2026-09-15 | 2,847,303 | -8.5% | 864,608 | 3.29 |
| 2026-08-31 | 3,111,476 | -7.4% | 1,007,589 | 3.09 |
| 2026-08-14 | 3,361,629 | -8.1% | 1,187,513 | 2.83 |
| 2026-07-31 | 3,659,421 | -13.9% | 1,689,672 | 2.17 |
| 2026-07-15 | 4,251,822 | -1.8% | 1,315,609 | 3.23 |
| 2026-06-30 | 4,327,430 | -31.6% | 1,726,267 | 2.51 |
| 2026-06-15 | 6,323,340 | +3.4% | 1,364,426 | 4.63 |
| 2026-05-29 | 6,117,059 | +2.1% | 1,139,058 | 5.37 |
| 2026-05-15 | 5,989,905 | -4.5% | 2,008,266 | 2.98 |
| 2026-04-30 | 6,275,283 | +15.7% | 2,060,260 | 3.05 |
| 2026-04-15 | 5,422,616 | -8.7% | 1,848,828 | 2.93 |
| 2026-03-31 | 5,937,118 | +19.3% | 1,708,634 | 3.47 |
| 2026-03-13 | 4,977,893 | -1.3% | 1,492,599 | 3.34 |
| 2026-02-27 | 5,043,434 | -3.1% | 1,789,843 | 2.82 |
| 2026-02-13 | 5,207,601 | -11.0% | 3,093,176 | 1.68 |
| 2026-01-30 | 5,853,871 | -4.1% | 3,298,581 | 1.77 |
| 2026-01-15 | 6,106,941 | +15.3% | 885,013 | 6.90 |
| 2025-12-31 | 5,295,934 | +9.9% | 1,120,112 | 4.73 |
| 2025-12-15 | 4,819,305 | +0.7% | 1,630,675 | 2.96 |
| 2025-11-28 | 4,784,843 | +12.8% | 1,591,041 | 3.01 |
| 2025-11-14 | 4,243,688 | +9.5% | 1,842,566 | 2.30 |
| 2025-10-31 | 3,876,253 | -2.4% | 1,379,937 | 2.81 |
| 2025-10-15 | 3,972,444 | +20.4% | 2,463,164 | 1.61 |
| 2025-09-30 | 3,299,575 | -19.1% | 1,982,258 | 1.66 |
| 2025-09-15 | 4,078,437 | -11.8% | 2,161,256 | 1.89 |
| 2025-08-29 | 4,625,645 | -12.2% | 1,203,994 | 3.84 |
| 2025-08-15 | 5,265,970 | +12.4% | 1,549,696 | 3.40 |
| 2025-07-31 | 4,682,779 | +9.5% | 2,423,426 | 1.93 |
| 2025-07-15 | 4,277,616 | -1.0% | 1,301,954 | 3.29 |
| 2025-06-30 | 4,322,192 | +1.6% | 1,774,263 | 2.44 |
| 2025-06-13 | 4,254,684 | +7.8% | 1,531,415 | 2.78 |
| 2025-05-30 | 3,944,929 | +14.7% | 1,973,004 | 2.00 |
| 2025-05-15 | 3,440,131 | +11.2% | 1,906,511 | 1.80 |
| 2025-04-30 | 3,094,804 | -0.9% | 1,933,073 | 1.60 |
| 2025-04-15 | 3,123,714 | -14.7% | 1,999,622 | 1.56 |
| 2025-03-31 | 3,660,873 | +9.9% | 1,300,575 | 2.81 |
| 2025-03-14 | 3,332,285 | -9.0% | 1,395,356 | 2.39 |
| 2025-02-28 | 3,660,419 | -14.8% | 1,692,881 | 2.16 |
| 2025-02-14 | 4,296,359 | -6.3% | 2,108,120 | 2.04 |
| 2025-01-31 | 4,582,728 | -11.4% | 1,691,689 | 2.71 |
| 2025-01-15 | 5,175,421 | -7.3% | 1,311,774 | 3.95 |
| 2024-12-31 | 5,581,342 | +25.4% | 2,217,463 | 2.52 |
| 2024-12-13 | 4,451,197 | -1.7% | 1,352,906 | 3.29 |
| 2024-11-29 | 4,529,482 | -0.4% | 1,563,584 | 2.90 |
| 2024-11-15 | 4,546,653 | +3.8% | 2,196,524 | 2.07 |
| 2024-10-31 | 4,379,317 | +15.9% | 2,431,955 | 1.80 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 28 October 2026, the short share of HUM volume is 39.1%, up 2.7 points over the last five sessions. Over the last 30 readings it ranged from 31.9% (26 October 2026) to 71.9% (19 October 2026). The latest reading is 11.2 points below the 30-session average of 50.2%, on 371K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-28 | 145K | 371K | 39.1% | 50 |
| 2026-10-27 | 107K | 177K | 60.6% | 0 |
| 2026-10-26 | 112K | 350K | 31.9% | 225 |
| 2026-10-23 | 166K | 459K | 36.1% | 2 |
| 2026-10-22 | 271K | 490K | 55.3% | 1 |
| 2026-10-21 | 180K | 493K | 36.4% | 6 |
| 2026-10-20 | 218K | 360K | 60.5% | 1 |
| 2026-10-19 | 313K | 435K | 71.9% | 0 |
| 2026-10-16 | 330K | 573K | 57.6% | 87 |
| 2026-10-15 | 216K | 415K | 52.1% | 16 |
| 2026-10-14 | 257K | 476K | 53.9% | 0 |
| 2026-10-13 | 430K | 816K | 52.7% | 3,581 |
| 2026-10-12 | 357K | 794K | 44.9% | 140 |
| 2026-10-09 | 1.2M | 2.5M | 48.3% | 8,335 |
| 2026-10-08 | 409K | 904K | 45.2% | 30 |
| 2026-10-07 | 369K | 698K | 52.9% | 2,600 |
| 2026-10-06 | 502K | 726K | 69.1% | 30 |
| 2026-10-05 | 339K | 557K | 60.8% | 110 |
| 2026-10-02 | 185K | 295K | 62.6% | 48 |
| 2026-10-01 | 200K | 357K | 56.1% | 59 |
| 2026-09-30 | 141K | 246K | 57.3% | 0 |
| 2026-09-29 | 297K | 545K | 54.5% | 1 |
| 2026-09-28 | 267K | 528K | 50.6% | 2 |
| 2026-09-25 | 414K | 859K | 48.2% | 361 |
| 2026-09-24 | 162K | 391K | 41.4% | 401 |
| 2026-09-23 | 114K | 281K | 40.5% | 489 |
| 2026-09-22 | 130K | 325K | 40.1% | 286 |
| 2026-09-21 | 119K | 272K | 43.8% | 0 |
| 2026-09-18 | 156K | 320K | 48.6% | 0 |
| 2026-09-17 | 100K | 296K | 33.7% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 21 September 2026, the fails-to-deliver balance in HUM is 2,598 shares, up 2,587 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (30 July 2026) to 44,156 shares (22 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-21 | 2,598 | $386.22 | $1.0M |
| 2026-09-15 | 11 | $407.02 | $4K |
| 2026-09-14 | 100 | $409.80 | $41K |
| 2026-09-02 | 83 | $394.88 | $33K |
| 2026-08-28 | 451 | $392.63 | $177K |
| 2026-08-25 | 44 | $386.61 | $17K |
| 2026-08-24 | 271 | $378.88 | $103K |
| 2026-08-10 | 1,000 | $385.00 | $385K |
| 2026-07-30 | 1 | $365.41 | $365 |
| 2026-07-10 | 13 | $397.76 | $5K |
| 2026-07-09 | 4,596 | $396.29 | $1.8M |
| 2026-07-06 | 12 | $396.75 | $5K |
| 2026-06-30 | 18 | $388.90 | $7K |
| 2026-06-25 | 280 | $361.64 | $101K |
| 2026-06-22 | 44,156 | $360.65 | $15.9M |
| 2026-06-15 | 2,200 | $379.22 | $834K |
| 2026-06-12 | 322 | $368.69 | $119K |
| 2026-06-08 | 1,000 | $350.08 | $350K |
| 2026-06-02 | 30 | $328.31 | $10K |
| 2026-06-01 | 5,100 | $305.42 | $1.6M |
| 2026-05-26 | 981 | $307.95 | $302K |
| 2026-05-20 | 56 | $310.55 | $17K |
| 2026-05-18 | 4,205 | $305.12 | $1.3M |
| 2026-05-11 | 1,011 | $274.96 | $278K |
| 2026-05-08 | 2,671 | $247.12 | $660K |
| 2026-05-07 | 1,931 | $246.33 | $476K |
| 2026-05-06 | 528 | $239.53 | $126K |
| 2026-05-05 | 500 | $237.96 | $119K |
| 2026-05-04 | 1,053 | $233.63 | $246K |
| 2026-04-30 | 21,273 | $243.12 | $5.2M |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for HUM in the last 90 days. The most recent filings are listed below. Latest filing: Nundy Shantanu (Chief Medical Officer) on 2026-09-01.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Nundy Shantanu | Chief Medical Officer | Grant | 3K | $0.00 | $0 | 3K |
| 2026-08-01 | Smith Paul John | Director | Grant | 544 | $0.00 | $0 | 544 |
| 2026-08-01 | Crawford Frederick John | Director | Grant | 544 | $0.00 | $0 | 544 |
| 2026-05-01 | Martin Aaron | President, Medicare Advantage | Grant | 8K | $0.00 | $0 | 25K |
| 2026-05-01 | Mehta Japan | Chief Information Officer | Grant | 9K | $0.00 | $0 | 17K |
| 2026-05-01 | Rechtin James A. | President & CEO | Grant | 36K | $0.00 | $0 | 64K |
| 2026-05-01 | Shetty Sanjay K | President, CenterWell | Grant | 10K | $0.00 | $0 | 22K |
| 2026-05-01 | O'Hara Michelle A. | Chief Human Resources Officer | Grant | 10K | $0.00 | $0 | 20K |
| 2026-05-01 | Ventura Joseph C | Chief Legal Officer | Grant | 10K | $0.00 | $0 | 27K |
| 2026-05-01 | Mellet Celeste | Chief Financial Officer | Grant | 15K | $0.00 | $0 | 40K |
| 2026-05-01 | Field Robert Stuart | Director | Grant | 852 | $0.00 | $0 | 852 |
| 2026-05-01 | Dintenfass David | President, Enterprise Growth | Grant | 11K | $0.00 | $0 | 25K |
| 2026-04-01 | Shetty Sanjay K | President, CenterWell | Tax withholding | 401 | $175.44 | $70K | 12K |
| 2026-04-01 | Shetty Sanjay K | President, CenterWell | Exercise or conversion | 887 | $0.00 | $0 | 13K |
| 2026-02-24 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Tax withholding | 84 | $177.07 | $15K | 7K |
| 2026-02-24 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Exercise or conversion | 165 | $0.00 | $0 | 8K |
| 2026-02-24 | Renaudin George II | President, Insurance | Tax withholding | 419 | $177.07 | $74K | 16K |
| 2026-02-24 | Renaudin George II | President, Insurance | Exercise or conversion | 1K | $0.00 | $0 | 16K |
| 2026-02-24 | Ventura Joseph C | Chief Legal Officer | Tax withholding | 478 | $177.07 | $85K | 17K |
| 2026-02-24 | Ventura Joseph C | Chief Legal Officer | Exercise or conversion | 1K | $0.00 | $0 | 18K |
| 2026-02-23 | Shetty Sanjay K | President, CenterWell | Buy | 810 | $185.21 | $150K | 12K |
| 2026-02-23 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Grant | 6K | $0.00 | $0 | 7K |
| 2026-02-21 | Dintenfass David | President, Enterprise Growth | Tax withholding | 1K | $189.66 | $224K | 14K |
| 2026-02-21 | Dintenfass David | President, Enterprise Growth | Exercise or conversion | 4K | $0.00 | $0 | 15K |
| 2026-02-13 | Mehta Japan | Chief Information Officer | Tax withholding | 430 | $181.46 | $78K | 8K |
| 2026-02-13 | Mehta Japan | Chief Information Officer | Exercise or conversion | 2K | $0.00 | $0 | 8K |
| 2026-02-13 | Mellet Celeste | Chief Financial Officer | Tax withholding | 4K | $181.46 | $763K | 24K |
| 2026-02-13 | Mellet Celeste | Chief Financial Officer | Exercise or conversion | 8K | $0.00 | $0 | 28K |
| 2026-02-12 | Martin Aaron | President, Medicare Advantage | Grant | 17K | $0.00 | $0 | 17K |
| 2026-01-08 | Rechtin James A. | President & CEO | Tax withholding | 980 | $279.15 | $274K | 28K |
| 2026-01-08 | Rechtin James A. | President & CEO | Exercise or conversion | 2K | $0.00 | $0 | 29K |
| 2026-01-02 | Mesquita Jorge S. | Director | Grant | 766 | $0.00 | $0 | 4K |
| 2026-01-02 | Feinberg David T | Director | Grant | 766 | $0.00 | $0 | 1K |
| 2026-01-01 | O'Hara Michelle A. | Chief Human Resources Officer | Tax withholding | 1K | $258.87 | $283K | 10K |
| 2026-01-01 | O'Hara Michelle A. | Chief Human Resources Officer | Exercise or conversion | 2K | $0.00 | $0 | 11K |
| 2025-12-15 | Mehta Japan | Chief Information Officer | Tax withholding | 470 | $270.15 | $127K | 8K |
| 2025-12-15 | Mehta Japan | Chief Information Officer | Exercise or conversion | 1K | $0.00 | $0 | 9K |
| 2025-12-15 | Rechtin James A. | President & CEO | Tax withholding | 3K | $270.15 | $911K | 27K |
| 2025-12-15 | Rechtin James A. | President & CEO | Exercise or conversion | 8K | $0.00 | $0 | 30K |
| 2025-12-15 | Shetty Sanjay K | President, CenterWell | Tax withholding | 139 | $270.15 | $38K | 11K |
| 2025-12-15 | Shetty Sanjay K | President, CenterWell | Exercise or conversion | 308 | $0.00 | $0 | 11K |
| 2025-12-15 | Shetty Sanjay K | President, CenterWell | Tax withholding | 888 | $270.15 | $240K | 11K |
| 2025-12-15 | Shetty Sanjay K | President, CenterWell | Exercise or conversion | 2K | $0.00 | $0 | 12K |
| 2025-12-15 | Renaudin George II | President, Insurance | Tax withholding | 142 | $270.15 | $38K | 15K |
| 2025-12-15 | Renaudin George II | President, Insurance | Exercise or conversion | 360 | $0.00 | $0 | 16K |
| 2025-12-15 | Renaudin George II | President, Insurance | Tax withholding | 830 | $270.15 | $224K | 15K |
| 2025-12-15 | Renaudin George II | President, Insurance | Exercise or conversion | 2K | $0.00 | $0 | 16K |
| 2025-12-15 | O'Hara Michelle A. | Chief Human Resources Officer | Tax withholding | 632 | $270.15 | $171K | 11K |
| 2025-12-15 | O'Hara Michelle A. | Chief Human Resources Officer | Exercise or conversion | 1K | $0.00 | $0 | 11K |
| 2025-12-15 | Ventura Joseph C | Chief Legal Officer | Tax withholding | 164 | $270.15 | $44K | 17K |
| 2025-12-15 | Ventura Joseph C | Chief Legal Officer | Exercise or conversion | 360 | $0.00 | $0 | 17K |
| 2025-12-15 | Ventura Joseph C | Chief Legal Officer | Tax withholding | 933 | $270.15 | $252K | 16K |
| 2025-12-15 | Ventura Joseph C | Chief Legal Officer | Exercise or conversion | 2K | $0.00 | $0 | 17K |
| 2025-12-15 | Mellet Celeste | Chief Financial Officer | Tax withholding | 1K | $270.15 | $330K | 28K |
| 2025-12-15 | Mellet Celeste | Chief Financial Officer | Exercise or conversion | 2K | $0.00 | $0 | 30K |
| 2025-12-15 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Tax withholding | 53 | $270.15 | $14K | 2K |
| 2025-12-15 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Exercise or conversion | 115 | $0.00 | $0 | 2K |
| 2025-12-15 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Tax withholding | 209 | $270.15 | $56K | 2K |
| 2025-12-15 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Exercise or conversion | 455 | $0.00 | $0 | 2K |
| 2025-12-15 | Dintenfass David | President, Enterprise Growth | Tax withholding | 918 | $270.15 | $248K | 15K |
| 2025-12-15 | Dintenfass David | President, Enterprise Growth | Exercise or conversion | 2K | $0.00 | $0 | 16K |
| 2025-11-01 | Smith Gordon | Director | Exercise or conversion | 765 | $0.00 | $0 | 765 |
| 2025-10-01 | Renaudin George II | President, Insurance | Tax withholding | 240 | $253.12 | $61K | 16K |
| 2025-10-01 | Renaudin George II | President, Insurance | Exercise or conversion | 609 | $0.00 | $0 | 16K |
| 2025-08-01 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Tax withholding | 97 | $248.41 | $24K | 2K |
| 2025-08-01 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Exercise or conversion | 211 | $0.00 | $0 | 2K |
| 2025-05-14 | Rechtin James A. | President & CEO | Buy | 7K | $229.25 | $1.5M | 30K |
| 2025-02-24 | Ventura Joseph C | Chief Legal Officer | Grant | 4K | $0.00 | $0 | 17K |
| 2025-02-24 | Renaudin George II | President, Insurance | Grant | 5K | $0.00 | $0 | 16K |
| 2025-02-24 | Agrawal Vishal | Chief Strat & Corp Dev Officer | Grant | 3K | $0.00 | $0 | 17K |
| 2025-02-24 | Dintenfass David | President, Enterprise Growth | Grant | 4K | $0.00 | $0 | 16K |
| 2025-02-24 | Mellet Celeste | Chief Financial Officer | Grant | 6K | $0.00 | $0 | 30K |
| 2025-02-24 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Grant | 876 | $0.00 | $0 | 2K |
| 2025-02-24 | Rechtin James A. | President & CEO | Grant | 19K | $0.00 | $0 | 24K |
| 2025-02-24 | O'Hara Michelle A. | Chief Human Resources Officer | Grant | 4K | $0.00 | $0 | 11K |
| 2025-02-24 | Shetty Sanjay K | President, CenterWell | Grant | 4K | $0.00 | $0 | 12K |
| 2025-02-24 | Mehta Japan | Chief Information Officer | Grant | 4K | $0.00 | $0 | 9K |
| 2025-02-21 | Ventura Joseph C | Chief Legal Officer | Exercise or conversion | 2K | $0.00 | $0 | 14K |
| 2025-02-21 | Ventura Joseph C | Chief Legal Officer | Tax withholding | 1K | $258.58 | $275K | 13K |
| 2025-02-21 | Renaudin George II | President, Insurance | Exercise or conversion | 732 | $0.00 | $0 | 11K |
| 2025-02-21 | Renaudin George II | President, Insurance | Tax withholding | 300 | $258.58 | $78K | 11K |
| 2025-02-21 | Agrawal Vishal | Chief Strat & Corp Dev Officer | Tax withholding | 905 | $258.58 | $234K | 13K |
| 2025-02-21 | Agrawal Vishal | Chief Strat & Corp Dev Officer | Exercise or conversion | 2K | $0.00 | $0 | 14K |
| 2025-02-21 | Dintenfass David | President, Enterprise Growth | Tax withholding | 1K | $258.58 | $304K | 12K |
| 2025-02-13 | Mehta Japan | Chief Information Officer | Grant | 5K | $0.00 | $0 | 5K |
| 2025-02-13 | Mellet Celeste | Chief Financial Officer | Grant | 23K | $0.00 | $0 | 23K |
| 2025-01-08 | Rechtin James A. | President & CEO | Tax withholding | 978 | $264.68 | $259K | 5K |
| 2025-01-08 | Rechtin James A. | President & CEO | Exercise or conversion | 2K | $0.00 | $0 | 6K |
| 2025-01-02 | Mesquita Jorge S. | Director | Grant | 783 | $0.00 | $0 | 3K |
| 2025-01-02 | SMITH BRAD D | Director | Grant | 783 | $0.00 | $0 | 1K |
| 2025-01-01 | O'Hara Michelle A. | Chief Human Resources Officer | Grant | 7K | $0.00 | $0 | 7K |
| 2024-12-31 | Huval Timothy S. | Chief Administrative Officer | Gift | 1K | $0.00 | $0 | 7K |
| 2024-12-31 | Huval Timothy S. | Chief Administrative Officer | Sell | 4K | $256.26 | $949K | 8K |
| 2024-12-15 | Agrawal Vishal | Chief Strat & Corp Dev Officer | Tax withholding | 140 | $271.68 | $38K | 12K |
| 2024-12-15 | Ventura Joseph C | Chief Legal Officer | Exercise or conversion | 359 | $0.00 | $0 | 12K |
| 2024-12-15 | Ventura Joseph C | Chief Legal Officer | Tax withholding | 165 | $271.68 | $45K | 11K |
| 2024-12-15 | Ventura Joseph C | Chief Legal Officer | Exercise or conversion | 362 | $0.00 | $0 | 12K |
| 2024-12-15 | Ventura Joseph C | Chief Legal Officer | Tax withholding | 164 | $271.68 | $45K | 12K |
| 2024-12-15 | Ventura Joseph C | Chief Legal Officer | Tax withholding | 259 | $271.68 | $70K | 11K |
| 2024-12-15 | Huval Timothy S. | Chief Administrative Officer | Tax withholding | 156 | $271.68 | $42K | 12K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON2 holders report 5% or more of HUM in their latest filing, all on Schedule 13G (passive). The largest reported stake is Dodge & Cox at 9.5% of the class (11,380,673 shares), filed 2026-05-14 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-05-14 | 13G/Ano. 1 | Dodge & Coxinvestment adviser | 11.4M | 9.5% | 2026-03-31 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 9.1M | 7.5% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 11 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding HUM at their latest 13F. JSON9 of the 30 tracked managers held HUM at their latest 13F, $546.2M in total at quarter-end prices. Citadel Advisors is the largest at $178.4M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 7 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 449K | $178.4M | 0.02% | +307K |
| Millennium Management | 2026-06-30 | 353K | $140.1M | 0.05% | +240K |
| AQR Capital Management | 2026-06-30 | 222K | $86.8M | 0.03% | +30K |
| D. E. Shaw & Co. | 2026-06-30 | 205K | $81.2M | 0.04% | -351K |
| Point72 Asset Management | 2026-06-30 | 98K | $39.1M | 0.04% | new |
| Soros Fund Management | 2026-06-30 | 33K | $13.2M | 0.16% | -34K |
| Bridgewater Associates | 2026-06-30 | 9K | $3.6M | 0.01% | new |
| Renaissance Technologies | 2026-06-30 | 9K | $3.4M | 0.00% | new |
| Fisher Asset Management | 2026-06-30 | 843 | $335K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q1 FY 2026 (quarter ended 2026-03-31) Humana reported revenue of $39.65B, up 23.5% from the same quarter a year earlier, and net income of $1.19B (9.83 diluted EPS). In FY 2025 it generated $921.0M of operating cash flow and spent $151.0M on buybacks and $430.0M on dividends. As of 2026-03-31, cash was $4.95B against $13.99B of debt.
- Cash
- $4.95B
- Debt
- $13.99B
- Equity
- $18.58B
- Total assets
- $55.28B
- Shares outstanding
- 120,061,500
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q1 FY 2026 | 2026-03-31 | $39.65B | $1.19B | 3.0% | 9.83 |
| Q4 FY 2025derived | 2025-12-31 | $32.52B | -$796.0M | -2.4% | n/a |
| Q3 FY 2025 | 2025-09-30 | $32.65B | $195.0M | 0.6% | 1.62 |
| Q2 FY 2025 | 2025-06-30 | $32.39B | $545.0M | 1.7% | 4.51 |
| Q1 FY 2025 | 2025-03-31 | $32.11B | $1.24B | 3.9% | 10.30 |
| Q4 FY 2024derived | 2024-12-31 | $29.21B | -$693.0M | -2.4% | n/a |
| Q3 FY 2024 | 2024-09-30 | $29.40B | $480.0M | 1.6% | 3.98 |
| Q2 FY 2024 | 2024-06-30 | $29.54B | $679.0M | 2.3% | 5.62 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $129.66B | $1.19B | $921.0M | $546.0M | $151.0M | $430.0M |
| FY 2024 | 2024-12-31 | $117.76B | $1.21B | $2.97B | $575.0M | $817.0M | $431.0M |
| FY 2023 | 2023-12-31 | $106.37B | $2.49B | $3.98B | $1.00B | $1.57B | $431.0M |
| FY 2022 | 2022-12-31 | $92.87B | $2.81B | $4.59B | $1.14B | $2.10B | $98.0M |
| FY 2021 | 2021-12-31 | $83.06B | $2.93B | $2.26B | $1.34B | $79.0M | $90.0M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-03-31; shares outstanding as of 2026-03-31 from the cover page.
What this page is
Humana in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Humana (HUM), SEC CIK 49071, listed on NYSE, classified by the SEC as hospital & medical service plans. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-28.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-21.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-05-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-03-31.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-29.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-01.JSON and CSV
- Company record
- EDGAR filing index for CIK 49071Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as hospital & medical service plans
Other company pages
Datasets
Frequently Asked Questions
How much of HUM is sold short?
3,665,781 shares were held short at the 2026-10-15 settlement, 2.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is HUM's daily short volume?
On 2026-10-28, 144,859 of the 370,680 HUM shares reported to FINRA were sold short, 39.1% of the day's reported volume. Short volume is a flow for one day, not a position.
Does HUM have fails to deliver?
The SEC's latest file shows 2,598 HUM shares failed to deliver at settlement 2026-09-21. Fails are reported per settlement date and published twice a month with a lag.
Are HUM insiders buying or selling?
No open-market insider trades were reported for HUM in the last 90 days. The most recent filings are listed below. Latest filing: Nundy Shantanu (Chief Medical Officer) on 2026-09-01.
Who owns 5% or more of HUM?
2 holders report 5% or more of HUM in their latest filing, all on Schedule 13G (passive). The largest reported stake is Dodge & Cox at 9.5% of the class (11,380,673 shares), filed 2026-05-14 for an event on 2026-03-31.
What did HUM report last quarter?
In Q1 FY 2026 (quarter ended 2026-03-31) Humana reported revenue of $39.65B, up 23.5% from the same quarter a year earlier, and net income of $1.19B (9.83 diluted EPS). In FY 2025 it generated $921.0M of operating cash flow and spent $151.0M on buybacks and $430.0M on dividends. As of 2026-03-31, cash was $4.95B against $13.99B of debt.
Which tracked 13F managers own HUM?
9 of the 30 tracked 13F managers held HUM shares at their latest filing, $546.2M in all. The largest: Ken Griffin's Citadel Advisors (449K shares, $178.4M), Izzy Englander's Millennium Management (353K shares, $140.1M), Cliff Asness's AQR Capital Management (222K shares, $86.8M), D. E. Shaw & Co. (205K shares, $81.2M), Steve Cohen's Point72 Asset Management (98K shares, $39.1M), George Soros's Soros Fund Management (33K shares, $13.2M). The table above lists all 9.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.